The Bengaluru-based drugmaker was caught trying to dispose quality-control records, the FDA said
The US Food and Drug Administration (FDA) has raised doubts about Strides Pharma Sciences Ltd’s quality–control practices after finding adulteration and evidence of “uncontrolled shredding of documents” at one of its plants. The FDA found “significant violations” of current good manufacturing practice…
